Edition:
United Kingdom

Michael Erman

Eli Lilly to offer half-priced versions of two more insulin products

14 Jan 2020

Eli Lilly and Co said on Tuesday it plans to sell two versions of insulin products at half their current U.S. list prices, eight months after it started selling a half-priced version of its widely-used Humalog injection.

Bristol-Myers confident of approvals linked to higher Celgene investor payout: Bristol executive

09 Jan 2020

NEW YORK Bristol-Myers Squibb Co is confident it will receive U.S. approvals for all three experimental drugs tied to a potentially higher payout for Celgene shareholders under terms of its acquisition of the U.S. biotech company, Bristol's chief medical officer said.

Novartis, Merck and Allergan join those raising U.S. drug prices for 2020

03 Jan 2020

NEW YORK Novartis AG, Merck & Co Inc and Allergan Plc were among companies that raised U.S. prices on more than 100 prescription medicines on Friday, bringing the tally to 445 drugs that will cost more in 2020, according to data analyzed by healthcare research firm 3 Axis Advisors.

More January U.S. price hikes take 2020 tally to over 330 drugs with higher cost

02 Jan 2020

NEW YORK AbbVie Inc on Thursday raised the cost of rheumatoid arthritis treatment Humira, the world's top-selling medicine, joining other drugmakers that have now hiked U.S. prices of more than 330 prescription drugs for 2020, according to data analyzed by healthcare research firm 3 Axis Advisors.

More January U.S. price hikes take 2020 tally to over 330 drugs with higher cost

02 Jan 2020

NEW YORK, Jan 2 AbbVie Inc on Thursday raised the cost of rheumatoid arthritis treatment Humira, the world's top-selling medicine, joining other drugmakers that have now hiked U.S. prices of more than 330 prescription drugs for 2020, according to data analyzed by healthcare research firm 3 Axis Advisors.

More drugmakers hike U.S. prices as new year begins

01 Jan 2020

NEW YORK Drugmakers including Bristol-Myers Squibb Co , Gilead Sciences Inc , and Biogen Inc hiked U.S. list prices on more than 50 drugs on Wednesday, bringing total New Year's Day drug price increases to more than 250, according to data analyzed by healthcare research firm 3 Axis Advisors.

Exclusive: Drugmakers from Pfizer to GSK to hike U.S. prices on over 200 drugs

01 Jan 2020

NEW YORK Drugmakers including Pfizer Inc , GlaxoSmithKline PLC and Sanofi SA are planning to hike U.S. list prices on more than 200 drugs in the United States on Wednesday, according to drugmakers and data analyzed by healthcare research firm 3 Axis Advisors.

Novartis in talks with patients upset about lottery-like gene therapy giveaway

20 Dec 2019

NEW YORK Novartis is in discussion with patient groups over its lottery-style free drug program for its multi-million-dollar gene therapy for spinal muscular atrophy (SMA) after criticism that the process could be unfair to some babies with the deadly disease.

World News